Two-day event in Springfield aimed to create blueprint to improve rural health Springfield, Ill. –SIU School of Medicine Department of Population Science and Policy, Paul Simon Public Policy Institute, UIC School of Public Health, SIU School of Medicine Center for Rural Health and Social Service Development and the Illinois Department of Public Health hosted an influential group of rural health experts and stakeholders at the 2018 Illinois Rural Health Summit in Springfield, Illinois on August 6-7. The two-day event gathered information and inspiration to begin drafting and executing a

Dr. Ricardo Loret de Mola and Dr. Kanako Hayashi were honored with the award for the best poster at the 4 th European Congress on Endometriosis in Vienna, Austria. The poster entitled “Suppression of inflammatory responses in endometrial lesions by reducing the secretion of cytokines and chemokines” is the result of a collaborative effort between Dr. Loret de Mola a clinical expert in the field of reproductive endocrinology with a special interest in endometriosis and Dr. Hayashi, a discovery science researcher at the SIU Carbondale campus who has years of experience studying female

Alzheimer’s is a devastatingly progressive disease that robs our loved ones of their memories and personalities. Presently 5.7 million Americans are living with Alzheimer’s. By 2050, this number is projected to rise to nearly 14 million. Early and accurate diagnosis could save up to $7.9 trillion in medical and care costs, according to the Alzheimer’s Association. There is increasing evidence that Alzheimer’s disease lies on a continuum with dynamic neurobiological and pathological symptoms. As the disease progresses, targeting specific therapeutic windows for intervention may give patients

Alzheimer’s is a devastatingly progressive disease that robs our loved ones of their memories and personalities. Presently 5.7 million Americans are living with Alzheimer’s. By 2050, this number is projected to rise to nearly 14 million. Early and accurate diagnosis could save up to $7.9 trillion in medical and care costs, according to the Alzheimer’s Association. There is increasing evidence that Alzheimer’s disease lies on a continuum with dynamic neurobiological and pathological symptoms. As the disease progresses, targeting specific therapeutic windows for intervention may give patients

Alzheimer’s disease could affect more than 14 million Americans by 2050 if a cure isn’t found, the Alzheimer’s Association reports. The Center for Alzheimer’s Disease and Related Disorders, part of SIU Medicine’s Neuroscience Institute, is hoping new research studies might change that. Three clinical trials, including the Aware Study by AbbVie, Tauriel Study by Genentech, and GRADUATE I Study by Roche, are now recruiting participants with memory impairment or probable mild-to-moderate Alzheimer’s disease. The goal of these studies is test how well the medical treatments work at slowing the

Alzheimer’s disease could affect more than 14 million Americans by 2050 if a cure isn’t found, the Alzheimer’s Association reports. The Center for Alzheimer’s Disease and Related Disorders, part of SIU Medicine’s Neuroscience Institute, is hoping new research studies might change that. Three clinical trials, including the Aware Study by AbbVie, Tauriel Study by Genentech, and GRADUATE I Study by Roche, are now recruiting participants with memory impairment or probable mild-to-moderate Alzheimer’s disease. The goal of these studies is test how well the medical treatments work at slowing the

SPRINGFIELD, ILLINOIS: If you could take a drug that would help cure your cancer, but it would make you go deaf, would you still take the drug? Cisplatin is a widely used anticancer drug that unfortunately carries some major side effects, including hearing loss and damage to the nerves and kidneys. Its high toxicity often requires dose reductions or the use of less effective alternate drugs. Cisplatin-induced hearing loss can range from 50-75 percent in adults. When the drug is used to treat neuroblastomas in pediatric cancer patients, extreme care must be taken because hearing loss can hamper